As of 3:59pm ET
| +0.30 / +13.76%|
The 3 analysts offering 12-month price forecasts for Cocrystal Pharma Inc have a median target of 10.00, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +303.23% increase from the last price of 2.48.
The current consensus among 2 polled investment analysts is to Buy stock in Cocrystal Pharma Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.